当前位置: X-MOL 学术Lancet Neurol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Unravelling the heterogeneity of epilepsy for optimal individualised treatment: advances in 2019.
The Lancet Neurology ( IF 46.5 ) Pub Date : 2020-01-01 , DOI: 10.1016/s1474-4422(19)30430-2
Page B Pennell 1
Affiliation  

One of the biggest challenges in epilepsy research is the vast heterogeneity of the disorder, including differences in causes, seizure types and severity, neurophysiological and neuroimaging characteristics, comorbidities, and the individual factors that should be considered in treatment selection. In 2019, advances have allowed this heterogeneity to be deciphered with new clinical tools to deliver safer and more personalised, effective treatments to each of the 50 million people with epilepsy worldwide.

中文翻译:

揭示癫痫的异质性以获得最佳个体化治疗:2019年取得进展。

癫痫研究的最大挑战之一是该疾病的巨大异质性,包括原因,癫痫发作类型和严重程度,神经生理学和神经影像学特征,合并症以及治疗选择时应考虑的各个因素之间的差异。在2019年,技术的进步使得这种异质性可以通过新的临床工具来解读,从而为全球5000万癫痫患者中的每一个提供更安全,更个性化的有效治疗方法。
更新日期:2019-12-13
down
wechat
bug